Condition
Clinical Stage IIB Cutaneous Melanoma AJCC v8
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
3 shownComparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) ProgramNCT06265285 · 2024-04-30
RECRUITINGRole of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerNCT03819296 · 2021-02-21
RECRUITINGSocial Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer SurvivorsNCT07259304 · 2021-11-24
ACTIVE_NOT_RECRUITINGCommon interventions
Best PracticeOTHER1Biospecimen CollectionOTHER1Endoscopic ProcedurePROCEDURE1Fecal Microbiota TransplantationPROCEDURE1Home Health EncounterOTHER1InfliximabBIOLOGICAL1Laboratory Biomarker AnalysisOTHER1Medical Device Usage and EvaluationOTHER1NivolumabBIOLOGICAL1Patient MonitoringPROCEDURE1PrednisoneDRUG1Quality-of-Life AssessmentOTHER1Questionnaire AdministrationOTHER1Survey AdministrationOTHER1VedolizumabBIOLOGICAL1
Leading sponsors
Trial status mix
RECRUITING2
ACTIVE_NOT_RECRUITING1
Phase mix
PHASE11
PHASE21
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.